Schedule of Noncontrolling Interest of Stockholders' Equity (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
NCI - equity (deficit) - beginning of period			$ (2,369)
Net loss attributable to NCI	$ (1,199)	$ (266)	(1,877)	$ (702)
NCI - equity (deficit) - end of period	(911)		(911)		$ (2,369)
Noncontrolling Interest [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
NCI - equity (deficit) - beginning of period			(2,369)	$ (814)	(814)
NCI - equity (deficit) - end of period	$ (911)		(911)		(2,369)
Noncontrolling Interest [Member] | Veris Health Inc [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Investment in Veris Health Inc.			6
Net loss attributable to NCI			(73)
Noncontrolling Interest [Member] | Lucid Diagnostics Inc [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Net loss attributable to NCI			(1,782)		(1,503)
Lucid Diagnostics Inc. 2018 Equity Plan stock option exercise					5
Stock-based compensation expense - Lucid Diagnostics Inc 2018 Equity Plan			3,329		52
Noncontrolling Interest [Member] | Solys Diagnostics Inc. [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Net loss attributable to NCI			$ (22)		$ (109)